MVA Investors, LLC
CIK 1468223 · last filed 2024-07-02
MVA Investors, LLC is a corporate insider who has filed 17 SEC Form 4 insider transactions across 3 companies since 2013. The most recent filing shows the insider sold $4.1M of TNGX on Jul 2, 2024. Across all open-market trades the lifetime net is +$614.5M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $4.7M across reported positions. The firm reports its address in San Diego, CA. 39 SEC filings were submitted jointly with Boxer Capital, LLC.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$4.70M
3
17
$614.52M
Filer Profile
SUITE 300
SAN DIEGO, CA 92130
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TNGX | 208,793 | $22.52 | $4.70M | $37.53M | 3 | 2024-07-02 | |
| Mirati Therapeutics, Inc. (MRTX) Delisted | 10%+ Owner | 3,248,957 | $58.70 | $190.71M | $544.99M | 9 | 2023-08-15 |
| SOPHIRIS BIO INC. (SPHS) Delisted | 10%+ Owner | 246,153 | — | — | $32.00M | 1 | 2013-08-20 |
Recent Filings
17 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-07-02 | TNGX | Sell (S) | −469,462 | -$4.11M | EDGAR |
| 2024-06-07 | TNGX | Sell (S) | −280,000 | -$1.97M | EDGAR |
| 2024-05-03 | TNGX | Notice (144) | −60,000 | -$455.4K | EDGAR |
| 2024-05-02 | TNGX | Notice (144) | −75,000 | -$546.0K | EDGAR |
| 2024-05-01 | TNGX | Notice (144) | −75,000 | -$577.5K | EDGAR |
| 2023-10-17 | TNGX | Buy (P) | +6,250,000 | $43.61M | EDGAR |
| 2023-10-10 | TNGX | Notice (144) | −50,000 | -$569.0K | EDGAR |
| 2023-08-15 | Mirati Therapeutics, Inc. (MRTX) Delisted | Buy (P) | +8,812,811 | $245.00M | EDGAR |
| 2023-08-15 | Mirati Therapeutics, Inc. (MRTX) Delisted | Buy (P) | +8,812,811 | $245.00M | EDGAR |
| 2019-07-15 | Mirati Therapeutics, Inc. (MRTX) Delisted | Other (J) | −5,547 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.